BFC
GCVRZ

Bedel Financial Consulting’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bedel Financial Consulting’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1
Closed – – 954
2019
Q4 		$0 Hold
1
– – ﹤0.01% 809
2019
Q3 		$0 Hold
1
– – ﹤0.01% 793
2019
Q2 		$0 Hold
1
– – ﹤0.01% 773
2019
Q1 		$0 Hold
1
– – ﹤0.01% 748
2018
Q4 		$0 Hold
1
– – ﹤0.01% 748
2018
Q3 		$0 Hold
1
– – ﹤0.01% 745
2018
Q2 		$0 Hold
1
– – ﹤0.01% 749
2018
Q1 		$0 Buy
+1
New – ﹤0.01% 708

Bedel Financial Consulting's GCVRZ Position: Q1 2020 in Review

Bedel Financial Consulting sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 1 share.

Bedel Financial Consulting first reported a position in GCVRZ in Q1 2018 and held it in 8 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Bedel Financial Consulting reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Bedel Financial Consulting sold 1 Sanofi Contingent Value Rights share in Q1 2020.
  • Bedel Financial Consulting first reported a position in Sanofi Contingent Value Rights in Q1 2018 and held it in 8 quarters.
  • Bedel Financial Consulting's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Bedel Financial Consulting's 13F filing for Q1 2020, filed 6 May 2020.